When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Teva Pharmaceutical Industries Limited American Depositary Shares
Preface
Shares of Neurocrine Biosciences (NBIX) are up nearly 40% since I published the article, in December 2018, citing my belief that shares of NBIX would see $100 again. At that time, Neurocrine had revealed disappointing data in Tourette's and traded in the low $70s. Since then, pipeline developments and Ingrezza earnings beats have buoyed shares considerably:
The following article will update investors on the most recent earnings beat and upcoming catalysts.
Ingrezza Beats Expectations
Neurocrine announced recently that Ingrezza procured $181M in revenue for the last quarter (Q2), beating expectations ($150M)